Did you know? There are different kinds of changes, called mutations, that can happen in the MET gene. These changes can help cancer grow and spread. One type is called c-MET overexpression. This means the cancer cells make too [...]
A statement from GO2 for Lung Cancer’s President and CEO Laurie Ambrose on the proposed federal budget cuts The President recently submitted a Fiscal Year 2026 budget request that proposes yet again deep cuts to and elimination of key [...]
WASHINGTON, May 1, 2025 – As the nation recognizes May as Women’s Health Month, GO2 for Lung Cancer (GO2) is proud to celebrate a milestone: the Women and Lung Cancer Research and Preventive Services Act of 2025 (H.R. 2319) [...]
GO2 for Lung Cancer remains at the forefront of leading advocacy efforts to restore funding for the Lung Cancer Research Program. In preparation for today’s Senate Appropriations Committee hearing, “Biomedical Research: Keeping America’s Edge in Innovation,” we submitted written [...]
In early March, we surveyed the GO2 community to understand how recent federal executive orders are affecting patients, loved ones, healthcare providers, and researchers. Themes from 239 completed surveys covered 4 key areas: Impact on daily life or work [...]
Question: I’d like to start looking at whether a clinical trial might be good for me, but the process seems overwhelming. Where should I start? What are the best resources for me to understand my options? Answer: Whenever you [...]
A statement from GO2 President and CEO Laurie Ambrose I remember the day vividly in 2008. I succeeded in organizing a meeting with the Chairman of the House Appropriations Defense Subcommittee, Congressman John Murtha, to discuss establishing a dedicated [...]
WASHINGTON, March 25, 2025 — GO2 for Lung Cancer (GO2) announced it established the Global Advisory Council (GAC), a new group that brings together scientists, medical specialists, and other healthcare professionals from diverse disciplines who focus on GO2’s areas of impact: [...]
By Chaya Estrin-Lebovic, MPH, CHES, Registry Coordinator; John Wells MBA-HA, PMP, CSSGB, Manager Lung Cancer Registry; Courtney Granville, PhD, MSPH, Chief Scientific Officer Everyone living with lung cancer has unique experiences. Some people discover it unexpectedly—like the young mother [...]
GO2 for Lung Cancer stands alongside patients, families, healthcare providers, researchers, and the broader medical community in our mission to increase survival for those at risk, diagnosed, and living with lung cancer. On January 27, 2025, the Office of [...]